Cannabis Movers & Shakers: Plus Products, Arcview Capital, Greenspoon Marder, KetamineOne, Open Book Extracts, Cannabics Pharmaceuticals, Sundial, Flora Growth

Plus Products Appoints Tara Soltow as Vice President of Marketing

Cannabis and hemp branded product company Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) a hired Tara Soltow to take on the role of VP of Marketing.

The move follows Matt Schmidt’s recent decision to step down from the company’s board of directors.

In his new position, Soltow to oversee brand, digital and e-commerce marketing efforts.

Previously, she was a marketing consultant for Plus Products.

Soltow brings over 16 years of marketing experience, having worked for several lifestyle brands in the beer, wine and spirits and gambling industries.

“I am delighted to continue my work with PLUS, an incredible leader in the industry whom I have admired since its inception,” Soltow told Benzinga. “I am excited to be working alongside our leading team as we continue to launch new innovations, reach consumers and commerce with meaningful and impactful programming, and ultimately set the standard for creating mark in the edible space. “

Jake heimark, CEO and co-founder of the company, said he was delighted to welcome Soltow to the team.

“Tara has a proven track record of successful cannabis marketing and at PLUS she was instrumental in launching our strains and hash candies and our 4/20 consumer marketing campaign. “, he added.

Arcview Capital Hires Chris Reece as Managing Director

Capital of Arcview revealed on Wednesday that he had hosted Chris Reece in its ranks.

Reece will serve as the managing director of the New York-based company. He brings years of experience in the design, management and sale of investments for corporate and retail clients.

“We are ready for private business transactions, crowdfunding and the development of different options for investment strategies” Jeff Pasquerella, founder of Arcview Capital, said Wednesday. “By working with startups, start-ups and emerging companies to raise capital, Chris Reece and his team are able to provide clients with the support they need along their journey. “

Greenspoon Marder Strengthens Midwest Cannabis Law Practice, Appoints New President

Business law firm Marder green spoon said Tuesday it’s expanding its cannabis law practice group by hiring five new attorneys to work at its Chicago site.

Gerry Green Spoon, Co-Managing Director of Greenspoon Marder, said he was “delighted to strengthen our core cannabis practice by welcoming this team of cannabis lawyers.”

The following experts will join the Chicago-based firm:

  • Nick richards, who was appointed chair of the Cannabis Law practice group. He brings experience in representing individuals and companies in the context of tax audits and litigation, mergers and acquisitions, in tax debt management, while also advising companies, owners and companies. cannabis investors on tax and regulatory compliance issues.
  • Irina Dachevski has extensive knowledge of the cannabis industry. She provides advisory advice on legal issues and legislative developments in the field of cannabis.
  • Ryan holz focuses on cannabis laws in the United States and advises clients on complex legal and business issues affecting cannabis-related businesses.
  • at Doug Sargent a comprehensive understanding of U.S. cannabis laws provide advisory advice on legal and regulatory issues related to operation within the cannabis industry in the areas of licensing, compliance, regulatory matters and litigation.

  • David Standa advises cannabis customers throughout the Midwest on state licensing and taxation matters, as well as compliance with seed-to-sale and litigation tracking requirements.
  • Robert johnson, who joins the firm as counsel, brings more than 25 years of experience in the legal, commercial, franchising and crisis management fields.

Additionally, Dashevsky, Holz, Sargent and Standa have joined Greenspoon Marder’s Cannabis Law practice group as partners.

KetamineOne appoints Adam Deffett interim CEO, Robert Meister resigns

KetamineOne Capital Limited revealed on Wednesday that its board of directors appointed Adam Deffett becomes Interim CEO.

Deffett has also agreed to continue serving as the company’s vice president of capital markets.

Robert Meister, the former CEO of the Vancouver-based company, has resigned his position and has also resigned from the board of directors.

Deffett is a senior capital markets professional who brings over 15 years of experience in the Canadian equity markets.

“I greatly appreciate the opportunity to lead Ketamine One during this exciting time as we realize our vision to become a leader in mental health and wellness in North America,” said Deffett.

Open Book Extracts strengthens the management team with three experts

CBD producer Extracts from open books announced a series of leadership changes Wednesday.

The company based in Roxboro, North Carolina hired Nicole Lemus as Director of Revenue, Andrea Groncy as Senior Director of Project Management and Sales and Brad Jones as Director of Technical Sales.

Before joining OBX, Lemus worked at Vit-Best Nutrition as Director of Growth. She brings more than two decades of experience guiding organizations through revenue transformation, aggressive growth, increased profitability and brand elevation.

Groncy has over 12 years of nutraceutical experience, having worked as the most successful sales director and project manager in project management.

Jones is an expert in the cannabis industry with extensive knowledge of strategy, operations and technical sales. He is a technical expert in extraction, purification and separation technologies. Prior to that, Jones worked at Folium Biosciences as Vice President of Technical Sales and Director of Production.

“Lemus, Groncy and Jones bring their knowledge and expertise to scale world-class teams, capitalizing on changing market dynamics and fostering a customer-centric mindset. They will be a considerable asset for OBX ” Dave Neundorfer, CEO of OBX, said.

Cannabics Pharmaceuticals Appoints Dr Inbar Maymon-Pomeranchik to Board of Directors

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) typed Dr Inbar Maymon-Pomeranchik to sit on its board of directors.

Maymon-Pomeranchik is trained as a molecular and genetic researcher with nearly two decades of executive level experience in biotechnology sciences and expertise in the global medical cannabis industry.

Maymon-Pomeranchik is the Founder and CEO of AgChimedes Group Ltd., BioDiligence, Executive Director of Ananda Developments Pls (UK), Director of NRGene and Member of the Advisory Board of Avida Global Ltd.

“As a new Independent Director, Inbar undoubtedly brings significant added value to our company, given her extensive global leadership experience in our industry, in leadership positions, as well as her in-depth scientific knowledge in technical analysis. new and innovative technologies ” Eyal Barad, CEO and co-founder of Israeli company CBD, said Wednesday.

The sundial elects the directors

The shareholders of the Calgary-based company Sundial Growers Inc. (NASDAQ: SNDL) elected the the following five candidates for director positions:

  • Greg Mills
  • Zach Georges
  • Bryan pinney
  • Gregory Turnbull
  • Lori Ell

Flora Growth welcomes ecologist Brigitte Baptiste as strategic advisor

Flora Growth Corp. (NASDAQ: FLGC) operated Brigitte Baptiste as strategic advisor.

Baptiste will participate in the research and development of the company’s sustainable and bioprospecting initiatives and will work on the development of new cannabis and hemp research programs at EAN University.

Baptiste is an environmental expert and ecologist specializing in Colombia.

“Having a consciously managed supply chain and responsibility to the planet is essential for success these days, as consumers now demand to know what’s in and behind the products and brands they buy. Baptiste said Thursday. “I am delighted to be working with the Flora team as we are aligned with creating and bringing to market sustainable products that consider the environment, biodiversity and sustainable business practices. “

Photo by David Gabrić on Unsplash


Source link

About Catherine Sherrill

Check Also

The Closed System Transfer Device market is expected to witness notable growth owing to the increase in the use of oncology drugs and the emergence of new protocols in the pharmaceutical industry, according to TMR

ALBANY, NY, 23 November 2021 / PRNewswire / – The growing adoption of closed system …

Leave a Reply

Your email address will not be published. Required fields are marked *